Jump to content

Cadralazine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 17:56, 17 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Cadralazine
Cadralazine molecule
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
  • Ethoxy-N'-{6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl}carbohydrazide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H21N5O3
Molar mass283.332 g·mol−1
3D model (JSmol)
  • O=C(OCC)NNc1nnc(N(CC(O)C)CC)cc1
  • InChI=1S/C12H21N5O3/c1-4-17(8-9(3)18)11-7-6-10(13-15-11)14-16-12(19)20-5-2/h6-7,9,18H,4-5,8H2,1-3H3,(H,13,14)(H,16,19) ☒N
  • Key:QLTVVOATEHFXLT-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Cadralazine is an antihypertensive of the hydrazinophthalazine chemical class.

References

Stub icon

This antihypertensive-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Cadralazine&oldid=963077101"